Significantly Enriched Pathways. by Jiyong Zhang (2498740)

“…By comparing samples from NAFLD patients and healthy controls, we identified 1,770 significant DEGs, with 1,073 being upregulated and 697 downregulated. …”

Gene specific primers used for <i>GmNN1/FT2a</i> fine mapping. by Xinxin Li (281237)

Comparison of fat utilization during exercise in follicular and luteal phases. # significant difference with follicular phase. by Maryam Mirzaei Khalil Abadi (19964324)

Subjects:

DataSheet_1_Sequential therapy with supercharged NK cells with either chemotherapy drug cisplatin or anti-PD-1 antibody decreases the tumor size and significantly enhances the NK f... by Kawaljit Kaur (1496686)

Items showing statistically significant differences in anxiety, engagement, and perceived learning between VR and HF simulations. by Sejin Kim (11909203)

Subjects:

Fold differences in Euclidean distance values may differentiate samples with HLA antibody pattern deviations from patient history. by Caleb Cornaby (5105225)

Significant spearman rank-order correlations amongst task and selected trait measures. by Akila Kadambi (6192359)

The effect of inotodiol on autophagy in HCC cells. *significantly different from control group. by Yushuang Xing (20636685)

Absolute and relative frequencies of the significance of the meta-analyses using the four different heterogeneity methods. by Samer Mheissen (8748501)

Temporal profiles of the key BO-NN features. by Julia Berezutskaya (9080269)

“…The shifts associated with non-significant prediction accuracies are greyed-out. <b>(c)</b> The results of the MDS for the key BO-NN features. …”

Twenty proteins were significantly different in plasma exosomes between the PE and control groups (12 upregulated; 8 downregulated). by Yonggang Zhang (38357)

Conditions for adapting workflows for secondary use (documentation and obtain consent); significance of group differences (n = 390). by Anja Köngeter (17959136)

Concerns about providing patients’ clinical data for secondary use and significance of group differences (n = 382). by Anja Köngeter (17959136)

Averaged muscle synergy vectors and muscle synergy vectors for all the subjects of the Control Group (CON) and Subacromial Impingement Syndrome Group (SIS) (UA–arbitrary units). by Rahman Sheikhhoseini (17559222)

Subjects:

Averaged Inter-individual variability of Synergy activation coefficients for all the subjects of Control Group (CON) and Subacromial Impingement Syndrome Group (SIS) (UA—arbitrary... by Rahman Sheikhhoseini (17559222)

Subjects:

Averaged EMG envelopes (UA—arbitrary units) from 8 muscles obtained in Subacromial Impingement Syndrome Group (SIS) and Control Group (CON) participants during the RRT (200-time po... by Rahman Sheikhhoseini (17559222)

Subjects:

Mean ± SD values of variance accounted for (VAF) relative to the original extraction iteration of muscle synergies for the Control Group (CON) and Subacromial Impingement Syndrome... by Rahman Sheikhhoseini (17559222)

Subjects:

Mean ± SD values of variance accounted for each muscle (VAF muscle) regarding a three-synergy model for the repetitive reaching task (RRT). by Rahman Sheikhhoseini (17559222)

Subjects:

The laboratory setup for the repetitive movement task machine is showed from the front-right (A) and top (B) views. by Rahman Sheikhhoseini (17559222)

Subjects:

Intra-group and inter-group similarity values (r _max) and lag times (%) of synergy activation coefficients and individual EMG profiles of Control Group (CON); Subacromia... by Rahman Sheikhhoseini (17559222)

Subjects: